Access the complete Neuronet Knowledge Base here: https://kb.imi-neuronet.org/
Neuronet is collecting information from the Innovative Medicines (IMI) Initiative's neurodegeneration (ND) projects on the key assets resulting from their projects, presented in an explorable asset map format. These assets include datasets, biological samples, cohorts, disease models, taxonomies, platforms and tools, among others.
The Neuronet Asset Map is designed to provide a comprehensive overview of the assets from the IMI ND portfolio, categorised by R&D stage (non-clinical, clinical, regulatory and Real-World Evidence) and type. The asset map will be updated by Neuronet on a regular basis.